Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bacteria like the taste of syngas

04.12.2013
• Evonik laboratory studies have shown that biotech methods can be used successfully to produce specialty chemicals from waste gas
• Lessons learned from primordial bacteria
• A milestone for third-generation biotechnology

For the first time, Evonik Industries has managed to use biotech methods to convert syngas to pure 2-hydroxyisobutyric acid (2-HIBA) under industrial conditions. 2-HIBA is a precursor used in the manufacture of PLEXIGLAS®. Waste gas is one example of a source of syngas.

“We have shown that there is a safe way of using bacteria to turn syngas into a variety of products in the future,” says Dr. Peter Nagler, Evonik’s Chief Innovation Officer. In addition to 2-HIBA for the plastics industry, other products could include their derivatives for the cosmetics industry, or C4 alcohols for the paints and varnishes industry.

Syngases are gas mixtures consisting primarily of carbon monoxide or of carbon dioxide and hydrogen. These gases can be generated from municipal or agricultural waste, or from the waste gases produced in industries such as steel production. Syngas has been used for synthesizing chemicals for decades. For the ability to convert carbon monoxide, carbon dioxide, and hydrogen into more valuable molecules, Evonik looked to bacteria from earth’s earliest history—to a time when oxygen was not yet present in earth’s atmosphere. Certain microorganisms today still contain the genetic information for these processes. Evonik has used their enzymes to create a cell factory that generates specialty chemicals from syngas.

Evonik scientists are now working at top speed to optimize these ideas and develop them still further. “We have a long way to go before we can use bacteria for converting syngas to high-quality specialty chemicals on a large industrial scale,” says Dr. Thomas Haas, head of Biotechnology at Creavis, Evonik’s strategic innovation unit. “It will still take a couple of years until it is ready for the market.”

Evonik views biotechnology as a field with tremendous potential for innovation. The specialty chemicals manufacturer is already using biotech methods to produce high-quality products. These first-generation industrial biotechnology processes involve the use of plant oils, grains, and sugars as raw materials for fermentation. Evonik uses these materials to produce amino acids and cosmetic ingredients, among other products. The first second-generation biotechnology plants are currently under construction, and these utilize residual plant materials from agriculture and forestry. Evonik is only pursuing a few projects in this area, and is instead focusing more of its attention on third-generation biotechnology.

As Haas explains, “We’re exploring third-generation biotechnology, because in addition to sugar or residual plant materials converted to syngas, waste from other sources such as municipal waste and industrial waste gas can also serve as raw materials. That makes us less dependent not only on fossil-based raw materials, but also on renewable resources that could potentially compete with the food supply.”

2-HIBA can also be produced via chemical synthesis. Both the chemically-produced and biotech-produced products can be converted to methyl methacrylate (MMA). MMA is used in paints, varnishes, and anti-rust coatings, as well as in soft contact lenses and dental implants. Poly(methyl methacrylate) (PLEXIGLAS®) is used for creating sheets, profiles, roofs, soundproof walls, molded components for automotive engineering applications, and backlight units for illuminating flat-screen monitors and televisions. Evonik is one of the largest producers of MMA.

Following a resolution passed by the German Bundestag, this research is partly funded by the Federal Ministry of Food, Agriculture and Consumer Protection.

Company information
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).

Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Dr. Edda Schulze | idw
Further information:
http://www.evonik.com

More articles from Life Sciences:

nachricht Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel

nachricht Smelling the forest – not the trees
12.12.2018 | Universität Konstanz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

New discoveries predict ability to forecast dementia from single molecule

12.12.2018 | Health and Medicine

CCNY-Yale researchers make shape shifting cell breakthrough

12.12.2018 | Physics and Astronomy

Pain: Perception and motor impulses arise in the brain independently of one another

12.12.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>